APA

Bae S. K., Gushima T., Saito N., Yamanaka I., Matsuo Y., Yoshida S., Kawano I., Henzan H., Shimoda S., Eto T. & Takahashi K. (20200427). HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center. : Bone marrow transplantation.

Chicago

Bae Sung Kwan, Gushima Toshifumi, Saito Noriyuki, Yamanaka Ikumi, Matsuo Yayoi, Yoshida Shuro, Kawano Ichiro, Henzan Hideho, Shimoda Shinji, Eto Tetsuya and Takahashi Kazuhiro. 20200427. HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center. : Bone marrow transplantation.

Harvard

Bae S. K., Gushima T., Saito N., Yamanaka I., Matsuo Y., Yoshida S., Kawano I., Henzan H., Shimoda S., Eto T. and Takahashi K. (20200427). HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center. : Bone marrow transplantation.

MLA

Bae Sung Kwan, Gushima Toshifumi, Saito Noriyuki, Yamanaka Ikumi, Matsuo Yayoi, Yoshida Shuro, Kawano Ichiro, Henzan Hideho, Shimoda Shinji, Eto Tetsuya and Takahashi Kazuhiro. HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center. : Bone marrow transplantation. 20200427.